Zyban®, a GlaxoWellcome product, is heavily represented in studies at the 11th Annual World Conference On Tobacco Or Health. In this Vidyya issue, we bring you two summaries of new research that shows 1) that Zyban® can help smokeless tobacco users quit and 2) Zyban® can help recent quitters remain smoke-free for longer periods. Since Zyban® is so heavily represented in this issue, we've included the complete prescribing/package insert information for you.
Where possible, Vidyya likes to include information that we think might be helpful to your practice. We are happy to say that this issue includes two excellent, government-sponored, patient education handouts, both of which are about smokeless tobacco and are very up-to-date.
Readers can expect more tobacco and health related articles to appear in the coming week in Vidyya as news from this week's World Conference on Tobacco Or Health, an international summit of 4,000 leaders in medicine, health
government, business, advocacy, communications, and education becomes public. The six-day conference began today, Monday, August 7th in Chicago.
Articles in today's Vidyya are:
As always, we hope you enjoy the issue.